Fuse Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 12, 2021 at 01:28 pm EDT
Share
Fuse Medical, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 5.665 million compared to USD 4.010 million a year ago. Operating loss was USD 426,006 compared to USD 398,464 a year ago. Net loss was USD 85,480 compared to USD 423,431 a year ago. For the half year, sales was USD 10.105 million compared to USD 8.647 million a year ago. Operating loss was USD 855,969 compared to USD 1.646 million a year ago. Net loss was USD 538,803 compared to USD 1.707 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.
Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.
FUSE MEDICAL, INC. 
